Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertension-Reference-Cited by-同舟云学术

Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertension

Published:2002-11 Issue:11 Volume:30 Page:2489-2492
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Ghofrani Hossein A.,Rose Frank,Schermuly Ralph T.,Olschewski Horst,Wiedemann Ralph,Weissmann Norbert,Schudt Christian,Tenor Herrmann,Seeger Werner,Grimminger Friedrich

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference10 articles.

1. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

2. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension

3. Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension

4. Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled Trial

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Akute perioperative Rechtsherzinsuffizienz;Der Kardiologe;2018-01-31

2. Akute perioperative Rechtsherzinsuffizienz;Der Anaesthesist;2017-12-21

3. Phosphodiesterase 4 Inhibitors in Immune-mediated Diseases: Mode of Action, Clinical Applications, Current and Future Perspectives;Current Medicinal Chemistry;2017-09-25

4. Exploring dual PDE3/4 inhibition in the treatment of airway diseases;Drugs of the Future;2015

5. Intensivtherapie bei akuter Herzinsuffizienz, kardiogenem Schock und Herzbeuteltamponade;Die Intensivmedizin;2015